Rep. Gilbert Ray Cisneros, Jr. Buys Revvity Inc. (NYSE:RVTY) Shares

Posted by James Conley on Oct 15th, 2025

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Revvity Inc. (NYSE:RVTY). In a filing disclosed on October 10th, the Representative disclosed that they had bought between $1,001 and $15,000 in Revvity stock on September 12th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

Purchased $1,001 – $15,000 in shares of StandardAero (NYSE:SARO) on 10/1/2025.
Sold $1,001 – $15,000 in shares of Amdocs (NASDAQ:DOX) on 10/1/2025.
Purchased $1,001 – $15,000 in shares of Waters (NYSE:WAT) on 9/30/2025.
Sold $15,001 – $50,000 in shares of Fortive (NYSE:FTV) on 9/30/2025.
Purchased $1,001 – $15,000 in shares of StandardAero (NYSE:SARO) on 9/30/2025.
Purchased $1,001 – $15,000 in shares of APi Group (NYSE:APG) on 9/30/2025.
Sold $1,001 – $15,000 in shares of GoDaddy (NYSE:GDDY) on 9/30/2025.
Purchased $1,001 – $15,000 in shares of PTC (NASDAQ:PTC) on 9/30/2025.
Purchased $1,001 – $15,000 in shares of CoStar Group (NASDAQ:CSGP) on 9/30/2025.
Purchased $1,001 – $15,000 in shares of Mitsubishi Heavy Industries (OTCMKTS:MHVYF) on 9/30/2025.

Revvity Stock Up 0.0%

Shares of Revvity stock opened at $91.00 on Wednesday. The firm’s 50 day moving average price is $88.18 and its 200-day moving average price is $92.62. The company has a quick ratio of 2.75, a current ratio of 3.33 and a debt-to-equity ratio of 0.43. Revvity Inc. has a 52-week low of $81.36 and a 52-week high of $129.50. The company has a market cap of $10.56 billion, a P/E ratio of 38.56, a PEG ratio of 3.03 and a beta of 0.98.

Revvity (NYSE:RVTY – Get Free Report) last issued its quarterly earnings data on Monday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.14 by $0.04. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The firm had revenue of $720.28 million for the quarter, compared to the consensus estimate of $711.26 million. During the same quarter in the previous year, the firm earned $1.22 EPS. The company’s quarterly revenue was up 4.1% compared to the same quarter last year. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. On average, sell-side analysts predict that Revvity Inc. will post 4.94 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 7th. Stockholders of record on Friday, October 17th will be given a $0.07 dividend. The ex-dividend date of this dividend is Friday, October 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s payout ratio is presently 11.86%.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on RVTY. Evercore ISI cut their price objective on shares of Revvity from $108.00 to $106.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 7th. Weiss Ratings cut shares of Revvity from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, October 8th. Raymond James Financial reiterated an “outperform” rating and issued a $115.00 target price (down from $120.00) on shares of Revvity in a research note on Tuesday, July 29th. Stifel Nicolaus lowered their target price on shares of Revvity from $120.00 to $110.00 and set a “hold” rating for the company in a research note on Tuesday, July 29th. Finally, Wall Street Zen cut shares of Revvity from a “buy” rating to a “hold” rating in a research note on Sunday, August 3rd. Ten equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Revvity currently has a consensus rating of “Moderate Buy” and a consensus target price of $117.93.

Read Our Latest Report on Revvity

Institutional Trading of Revvity

Institutional investors and hedge funds have recently bought and sold shares of the business. CYBER HORNET ETFs LLC acquired a new stake in Revvity during the 2nd quarter valued at approximately $32,000. MUFG Securities EMEA plc acquired a new stake in Revvity during the 2nd quarter valued at approximately $34,000. UMB Bank n.a. lifted its stake in Revvity by 138.8% during the 2nd quarter. UMB Bank n.a. now owns 406 shares of the company’s stock valued at $39,000 after acquiring an additional 236 shares during the period. CVA Family Office LLC lifted its stake in Revvity by 79.0% during the 2nd quarter. CVA Family Office LLC now owns 410 shares of the company’s stock valued at $40,000 after acquiring an additional 181 shares during the period. Finally, New Age Alpha Advisors LLC acquired a new stake in Revvity during the 1st quarter valued at approximately $44,000. 86.65% of the stock is currently owned by institutional investors and hedge funds.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Revvity Company Profile

(Get Free Report)

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.